35. The Wrong Drug at The Wrong Time
Maybe one day, the medical profession will understand and improve the quality of the pieces of the puzzle of dementia. For now, though, the research and emphasis are more about dealing with the symptoms than addressing the cause and management of dementia. Why can we not do more training and improvements with the medical communities' skillset? Many questions need to be addressed.
Host Mary Anne Oglesby-Sutherly and producer Sue Duffield share the discrepancies and difficulties of a recent family's despair in treating and diagnosing their loved one. You'll feel their anger, shock, and broken hearts due to a short stay in a Geriatric Psychiatric Facility administering a cocktail of medications. The result was life-threatening and a debilitating brain bleed. Now, the family is facing one of life’s hardest decisions.
Due to a recent FDA ruling that approved a new medication for agitation for those living with dementia, many experts in the field of dementia are shaking their heads. Why? Because the FDA did not lift the “Black Box Warning" for those living with dementia. This episode will give viewers an insight into this new drug, Rexulti.
Counseling and fighting for families has been and will always be the heart of Mary Anne and The Veranda Ministries in Gallatin, TN. Human beings with dementia are just as valuable and important as anyone. There has to be a better way... People's lives are counting on it.
www.verandaministries.org